MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027

MARKET OUTLOOK
The immunohistochemistry market in the Middle East & Africa has been projected to depict growth in terms of revenue and expand with a CAGR of 6.75% during the forecast years 2019-2027, according to a report by Triton Market Research.
Saudi Arabia, Turkey, South Africa, the UAE and counties in rest of the Middle East & Africa have been studied for the immunohistochemistry market in the Middle East & Africa.
The geriatric population is rapidly increasing across the globe. According to the World Health Organization (WHO), the elderly population is expected to reach nearly 2 billion by 2050. This segment of the population is at an increased risk of developing chronic diseases. Regular tissue diagnosis is required for the treatment and management of such diseases, which is expected to positively impact the global immunohistochemistry market.
Closed systems help reduce the risks of carryover contamination and increase the detection sensitivity of samples. They are reagent-specific and perform better only with specific consumables. Those from other companies cannot replace these consumables. For instance, Roche Diagnostics' VANTAGE workflow solution works only with consumables manufactured by the company. These closed systems are expensive and are affordable only by hospital-based pathology and pharmaceutical company based drug discovery laboratories. Small pathology research laboratories and medical research centers that have limited medical budget cannot afford these expensive systems. This restricts the sales of closed systems, as small laboratories opt for instruments by local manufacturers that perform analysis with universal consumables. This factor restricts the growth of the market to a large extent.
COMPETITIVE OUTLOOK
Abcam Plc, Bio SB, Cell Signaling Technology, Inc., Merck Millipore, Danaher Corporation, Thermo Fisher Scientific, Inc., Abbott Laboratories, PerkinElmer, Inc., Siemens AG Healthcare, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioGenex and Histologix are some of the prime players in the market.

TABLE OF CONTENT
1. MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. HISTORY OF IMMUNOHISTOCHEMISTRY
2.2. VALUE CHAIN OUTLOOK
2.3. KEY INSIGHTS
2.4. MARKET ATTRACTIVENESS MATRIX
2.5. MARKET DRIVERS
2.5.1. IN-VITRO TECHNOLOGICAL ADVANCEMENTS
2.5.2. INCREASING CANCER OCCURRENCE
2.5.3. SWELLING HEALTHCARE SPENDING
2.5.4. RISING GERIATRIC POPULATION
2.5.5. INCREASING USE OF POC TESTING
2.6. MARKET RESTRAINTS
2.6.1. RESTRICTIONS OF CLOSED SYSTEMS
2.6.2. REIMBURSEMENT ISSUES
2.7. MARKET OPPORTUNITIES
2.7.1. INCREASING USE OF BIOMARKERS FOR DISEASE DIAGNOSIS
2.7.2. TECHNOLOGICAL ADVANCEMENTS
2.8. MARKET CHALLENGES
2.8.1. STRINGENT REGULATIONS
2.8.2. HIGH MAINTENANCE COST INFLUENCING THE MARKET GROWTH
3. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY PRODUCTS
3.1. ANTIBODIES
3.1.1. PRIMARY ANTIBODIES
3.1.2. SECONDARY ANTIBODIES
3.2. EQUIPMENT
3.2.1. SLIDE STAINING SYSTEMS
3.2.2. TISSUE MICROARRAYS
3.2.3. TISSUE PROCESSING SYSTEMS
3.2.4. SLIDE SCANNERS
3.2.5. OTHER EQUIPMENT
3.3. REAGENTS
3.3.1. HISTOLOGICAL STAINS
3.3.2. BLOCKING SERA AND REAGENTS
3.3.3. CHROMOGENIC SUBSTRATES
3.3.4. FIXATION REAGENTS
3.3.5. STABILIZERS
3.3.6. ORGANIC SOLVENTS
3.3.7. PROTEOLYTIC ENZYMES
3.3.8. DILUENTS
3.4. KITS
4. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY APPLICATIONS
4.1. DIAGNOSTICS
4.1.1. CANCER
4.1.2. INFECTIOUS DISEASES
4.1.3. CARDIOVASCULAR DISEASE
4.1.4. AUTOIMMUNE DISEASES
4.1.5. DIABETES MELLITUS
4.1.6. NEPHROLOGICAL DISEASES
4.2. DRUG TESTING
5. IMMUNOHISTOCHEMISTRY (IHC) MARKET OUTLOOK - BY END-USERS
5.1. HOSPITALS AND DIAGNOSTIC LABORATORIES
5.2. RESEARCH INSTITUTES
5.3. OTHER END-USERS
6. IMMUNOHISTOCHEMISTRY (IHC) MARKET - MIDDLE EAST AND AFRICA
6.1. COUNTRY ANALYSIS
6.1.1. SAUDI ARABIA
6.1.2. THE UNITED ARAB EMIRATES
6.1.3. TURKEY
6.1.4. SOUTH AFRICA
6.1.5. REST OF MIDDLE EAST AND AFRICA
7. COMPETITIVE LANDSCAPE
7.1. ABBOTT LABORATORIES
7.2. ABCAM PLC
7.3. AGILENT TECHNOLOGIES, INC.
7.4. BIOGENEX
7.5. BIO-RAD LABORATORIES, INC.
7.6. BIO SB
7.7. CELL SIGNALING TECHNOLOGY, INC.
7.8. DANAHER CORPORATION
7.9. F. HOFFMANN-LA ROCHE AG
7.10. HISTOLOGIX
7.11. MERCK MILLIPORE
7.12. PERKINELMER, INC.
7.13. SIEMENS AG HEALTHCARE
7.14. THERMO FISHER SCIENTIFIC, INC.
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY








TABLE LIST
TABLE 1 MIDDLE EAST AND AFRICA MARKET FOR IMMUNOHISTOCHEMISTRY BY REGION 2019-2027 ($ MILLION)
TABLE 2 CANCER MARKERS USED IN DIAGNOSIS AND TREATMENT
TABLE 3 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY PRODUCTS 2019-2027 ($ MILLION)
TABLE 4 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES BY TYPE 2019-2027 ($ MILLION)
TABLE 5 CLINICALLY IMPORTANT MONOCLONAL ANTIBODIES
TABLE 6 SECONDARY ANTIBODY SELECTIONS
TABLE 7 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 8 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS BY TYPE 2019-2027 ($ MILLION)
TABLE 9 HISTOLOGY STAINS AND ITS CATEGORIES
TABLE 10 COMMON FIXATIVES AND THEIR GENERAL TARGET ANTIGENS
TABLE 11 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
TABLE 12 KIT COMPONENTS ARE AVAILABLE FOR IHC OPTIMIZATION
TABLE 13 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 14 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS BY TYPE 2019-2027 ($ MILLION)
TABLE 15 SELECTED INFECTIOUS ETIOLOGIES OF AUTOIMMUNE DISEASES
TABLE 16 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY END USERS 2019-2027 ($ MILLION)
TABLE 17 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET BY COUNTRY 2019-2027 ($ MILLION)






FIGURE LIST
FIGURE 1 MIDDLE EAST AND AFRICA MARKET FOR IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 2 HISTORY OF IMMUNOHISTOCHEMISTRY
FIGURE 3 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 4 MIDDLE EAST AND AFRICA ANTIBODIES MARKET IN PRIMARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA ANTIBODIES MARKET IN SECONDARY ANTIBODIES 2019-2027 ($ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN SLIDE STAINING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN TISSUE MICROARRAYS 2019-2027 ($ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN TISSUE PROCESSING SYSTEMS 2019-2027 ($ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN SLIDE SCANNERS 2019-2027 ($ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA EQUIPMENT MARKET IN OTHER EQUIPMENT 2019-2027 ($ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN REAGENTS 2019-2027 ($ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA REAGENTS MARKET IN HISTOLOGICAL STAINS 2019-2027 ($ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA REAGENTS MARKET IN BLOCKING SERA AND REAGENTS 2019-2027 ($ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA REAGENTS MARKET IN CHROMOGENIC SUBSTRATES 2019-2027 ($ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA REAGENTS MARKET IN FIXATION REAGENTS 2019-2027 ($ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA REAGENTS MARKET IN STABILIZERS 2019-2027 ($ MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA REAGENTS MARKET IN ORGANIC SOLVENTS 2019-2027 ($ MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA REAGENTS MARKET IN PROTEOLYTIC ENZYMES 2019-2027 ($ MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA REAGENTS MARKET IN DILUENTS 2019-2027 ($ MILLION)
FIGURE 21 PHASES OF HISTOLOGICAL STAINING
FIGURE 22 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN KITS 2019-2027 ($ MILLION)
FIGURE 23 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN CANCER 2019-2027 ($ MILLION)
FIGURE 25 MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN INFECTIOUS DISEASES 2019-2027 ($ MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN CARDIOVASCULAR DISEASE 2019-2027 ($ MILLION)
FIGURE 27 MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN AUTOIMMUNE DISEASES 2019-2027 ($ MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN DIABETES MELLITUS 2019-2027 ($ MILLION)
FIGURE 29 MIDDLE EAST AND AFRICA DIAGNOSTICS MARKET IN NEPHROLOGICAL DISEASES 2019-2027 ($ MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN DRUG TESTING 2019-2027 ($ MILLION)
FIGURE 31 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN HOSPITALS AND DIAGNOSTIC LABORATORIES 2019-2027 ($ MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN RESEARCH INSTITUTES 2019-2027 ($ MILLION)
FIGURE 33 MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET IN OTHER END USERS 2019-2027 ($ MILLION)
FIGURE 34 SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 35 TURKEY IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 36 UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 37 SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)
FIGURE 38 REST OF MIDDLE EAST AND AFRICA IMMUNOHISTOCHEMISTRY MARKET 2019-2027 ($ MILLION)